Supply Chain and Delivery of Antimicrobial Drugs in Smallholder Livestock Production Systems in Uganda. by Dione, Michel Mainack et al.
ORIGINAL RESEARCH
published: 08 September 2021
doi: 10.3389/fvets.2021.611076
Frontiers in Veterinary Science | www.frontiersin.org 1 September 2021 | Volume 8 | Article 611076
Edited by:
Simeon Kaitibie,
Lincoln University, New Zealand
Reviewed by:
Sofia Boqvist,
Swedish University of Agricultural
Sciences, Sweden
Yaovi Mahuton Gildas Hounmanou,






Mott MacDonald Uganda Limited,
Kampala, Uganda
Francis Ejobi,
Research and Innovations, Soroti
University, Soroti, Uganda
Specialty section:
This article was submitted to
Veterinary Humanities and Social
Sciences,
a section of the journal
Frontiers in Veterinary Science
Received: 28 September 2020
Accepted: 27 July 2021
Published: 08 September 2021
Citation:
Dione MM, Amia WC, Ejobi F,
Ouma EA and Wieland B (2021)
Supply Chain and Delivery of
Antimicrobial Drugs in Smallholder
Livestock Production Systems in
Uganda. Front. Vet. Sci. 8:611076.
doi: 10.3389/fvets.2021.611076
Supply Chain and Delivery of
Antimicrobial Drugs in Smallholder
Livestock Production Systems in
Uganda
Michel Mainack Dione 1*, Winfred Christine Amia 2†, Francis Ejobi 3†, Emily Awuor Ouma 2
and Barbara Wieland 4,5
1 Animal and Human Health Program, International Livestock Research Institute, Dakar, Senegal, 2 Animal and Human Health
Program, International Livestock Research Institute, Kampala, Uganda, 3College of Veterinary Medicine, Animal Resources
and Biosecurity, Makerere University, Kampala, Uganda, 4 Animal and Human Health Program, International Livestock
Research Institute, Addis Ababa, Ethiopia, 5 Institute of Virology and Immunology, Mittelhaeusern, Switzerland
This study assessed the veterinary drug supply chain in Uganda, the constraints faced by
the actors, and how the challenges influence the use of antimicrobial (AMs) by livestock
farmers. We carried out stakeholder consultation workshops, key informant interviews
and a knowledge, practices, and awareness survey with actors of the veterinary drug
supply chain. We also profiled drugs stored in 23 urban and peri-urban drug shops in
Lira and Mukono districts to record the commonly sold drugs. The veterinary drug supply
chain is made of several actors including wholesalers, retailers, Animal Health Service
Providers (AHSP) and farmers. Nearly ninety per cent of drug retailers and veterinary
practitioners did not receive specialized training in veterinary medicine, and most of
veterinary practitioners have been in the drug business market for more than 10 years.
Antibiotics and anti-helminthics were the most stocked drugs by retailers, with antibiotics
ranking highest in terms of contribution to annual financial profits, accounting for 33%.
The choice of a drug by veterinary practitioners was mainly informed by past success
with efficacy of the drug, and financial capacity of the client (the farmer) to meet the
treatment cost. Many veterinary practitioners were not conversant with veterinary drug
policies of the country, with Mukono having a higher number (72%) compared to Lira
(37%). Veterinary practitioners from Lira district compared to Mukono and those mainly
serving small scale farmers relative to large scale smallholders were more knowledgeable
about antibiotics and AMR. Several supply chain constraints were identified as potential
drivers of misuse of antibiotics that could contribute to AMR. These included low level
of education of supply chain actors, particularly drug retailers, poor handling of drugs
at purchase and administration practices, low enforcement of policies and regulations,
and lack of awareness of stakeholders about policies that regulate drug use. Thus, future
interventions to reduce misuse of AM drugs in livestock production systems in Uganda
such as capacity building, should also target veterinary input suppliers, and deliberately
involve a strong policy advocacy component.
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INTRODUCTION
While access to quality drugs by livestock producers remains a
challenge, there is also misuse of drugs that are easily accessible.
The voluntary and involuntarymisuse of veterinary drugs such as
antimicrobials (AM) in food-producing animals has the potential
to generate residues in animal derived products (meat, milk,
eggs and honey) and poses a health hazard to the consumer
(1). For example, Dar et al. (2) reported that there is a high
level of farmer self-prescription, with around a third of countries
allowing over-the-counter sales of drugs. This situation is not
only an indicator of poor-quality animal health services and
animal husbandry practices but may also result in an increase
in AMR risks in both animals and humans. While high income
countries have improved structures to better monitor quality and
quantity of veterinary drugs in the market, as well as testing
AM residues in animal source foods, most low- and middle-
income countries such as Uganda face challenges to put in place
adequate systems to monitor veterinary drugs use in the livestock
sector. Since the structural adjustment programs in the 1980s, in
Uganda, like in many other sub-Saharian countries, the private
sector has contributed immensely to the delivery of animal health
services, and government’s role has become largely regulatory
(3). However, implementation of regulations and policies that
govern the delivery of veterinary drugs is a challenge due to lack
of resources and commitment of the government (4). Veterinary
input suppliers such as drug wholesalers, retailers and veterinary
practitioners are important actors in the drug supply chain, since
they play an important role in ensuring quality of products to
livestock farmers (5, 6). However, few studies have addressed
veterinary drugs supply chain issues, especially in relation to
AMR. The present study is a first step toward a comprehensive
assessment of the use of AMs in smallholder livestock systems
in Uganda. Its objectives are to understand the veterinary drug
supply chain, constraints faced by actors, assess knowledge,
practices, and awareness of veterinary drug suppliers on drug
use and management practices, document policy gaps and how
they influence the use of AMs. The study was implemented using
three approaches: (1) qualitative assessment and description of
the veterinary drug supply chains and its challenges; (2) profiling
of veterinary drugs stocked by retailers and description of sales
practices and (3) a KAP survey with veterinary practitioners




The study was conducted in Kampala, Mukono, and Lira districts
in Uganda. Kampala is the capital city of Uganda from where
major drug wholesalers carry out their business. Mukono district
is in central Uganda located 40 km from Kampala, with a
population of 596,804 people, of which 59% are involved in
agriculture (7). Because of the proximity to Kampala, livestock
farmers are assumed to have better access to veterinary drugs
and other animal health inputs. Lira District is in Northern
Uganda, about 300 km from Kampala, had an estimated human
population of 377, 800 in 2010. The economy of the district is
mainly based on agriculture, with 81% of the population engaged
in subsistence farming with cattle being the main source of
wealth, and bulls and oxen being a major source of traction,
particularly for plowing (8). Piggery has increasingly become an
important enterprise with 40% of sub-counties having piggery
as a priority enterprise (9). The two districts were purposively
chosen for their contrasting geographic situations to enable
comparison in relation to implications of the locations on
potential quality of veterinary inputs and their access by farmers.
Data Collection
Qualitative Assessment of the Veterinary Drug Supply
Chains
Consultation With Stakeholders of the Veterinary Drug
Supply Chains
Two workshops were held with stakeholders of the veterinary
drug supply chains in Mukono district (May 2016) and Kampala
(December 2017). These two areas were targeted because of their
high density of veterinary drugs shops. The workshops were
organized and facilitated by the researchers. Workshop reports
were developed at the end of each session. The discussions
during the workshops covered challenges faced by actors, and
recommendations to improve drug supply chains.
In Mukono, the workshop brought together private sector
such as drug stockists, government [District Veterinary Officer
(DVO) and drug inspector] and regulators [National Drug
Authority (NDA)]. The stakeholders were also sensitized on the
importance of application of best practices involving drug use,
handling, and storage.
In Kampala, participants in the workshop included public
and private veterinary services, drug retailers and the NDA and
researchers (Table 1).
Key Informant Interviews With Large-Scale Drug
Distributors (or Primary Wholesalers)
Independent in-depth face-to-face informal interviews were
carried out with executives of the two major veterinary drug
companies in the country at their headquarters in Kampala
in November 2017. The discussions focused on description of
the veterinary drug supply chains, as well as the regulatory
framework for drugs distribution (Table 1).
Veterinary Drug Profiling and Description of Drug
Sale Practices
Profiling of Veterinary Drugs Sold in the Market
The veterinary drug profiling survey was carried out by
researchers in Lira and Mukono districts in August and
September 2018, respectively. A list of registered veterinary
drug retail shops was obtained from the DVO of the respective
districts. Ten drug retailers in Lira and 13 in Mukono districts
were included in the study. Most drug shops were in urban and
peri-urban areas. The drug profiling exercise included recording
of all drugs that were stocked in these shops at the time of the
visits. The visit lasted an average of 4 h for each of the drug shops.
Each drug was listed independently by trade name, and other data
that were captured using photographic images included the active
Frontiers in Veterinary Science | www.frontiersin.org 2 September 2021 | Volume 8 | Article 611076
Dione et al. Antimicrobial Use in Livestock
TABLE 1 | Profile of participants to different activities.
Activity Location Target stakeholder Target information Number of
participants
Qualitative assessment and description of the veterinary drug supply chains
Stakeholder consultation
workshop
Mukono Private veterinarian (16), Drug stockist (7),
Researchers (2), National Drug Authority
(1), Senior Veterinary Inspector (1), District
Veterinary Officer (1), District Animal Health
Production Officer (1)
Document constraints in the drug supply
chains at district level
29
Kampala District Veterinary Officer (1); Drug stockist
(2); National Drug Authority officer (1);
Researcher (1).
Document constraints in the drug supply
chains at district level
5
Key Informant Interview Kampala* Distributor (primary wholesaler) Understand the drug supply chain 2
Veterinary drug profiling and drug sale practices
Drug profiling and informal
interview with drugs retailers
and field observations**
Lira Drug retailers Types of veterinary drugs sold and
document sale practices
10
Mukono Drug retailers 13
Quantitative survey on knowledge and awareness about AMR with veterinary practitioners
Survey on knowledge and
awareness of AMR and
related policies
Lira Veterinary practitioners knowledge, practices, and awareness on
drug use an awareness about policies and
regulations
32
Mukono Veterinary practitioners 68
*All large-scale veterinary drug distributors are in Kampala.
**Observations happened during the drug profiling in the same drug shops.
compound of the drug and indication for diseases which drugs
identified could be used to treat. The qualification of the retailer
and the number of years a specific drug has been on the market
were recorded (Table 1).
Informal Interview With Drug Retailers and Field
Observations
This activity was carried out purely ad-hoc. During the visits
to the drug shops, interactions between the buyers and the
drug stockists were observed and recorded. The researchers also
engaged in informal discussions whenever necessary with the
drug stockists to better understand their management practices
and those of livestock keepers (Table 1).
Survey With Veterinary Practitioners on
Knowledge, Practices, and Awareness
About AMR and Perception of Related
Policies
A list of all registered veterinary practitioners in urban and peri-
urban areas was provided by the DVO of the respective districts.
All registered veterinary practitioners were interviewed in both
districts (Lira, 32 andMukono, 68). Data on knowledge, practices
of drug use and awareness of AMR were collected through
a structured questionnaire. The questionnaire was digitalized
through ODK (Open Data Kit) installed on tablets and uploaded
to a server. The questionnaire was pre-tested by the researchers
and refined before being administered by trained extension
agents who operate in the study areas (Table 1).
Data Management and Analysis
Qualitative Analysis
The qualitative data was collected by researchers in notebooks
during workshops, interviews, and field visits to drug shops,
from which field reports were derived. The analysis of data
involved extraction and linking information on identified themes
including “stakeholder mapping, practices, policy challenges,
recommendations”, pre-defined key themes such as challenges
faced by drug supply chain actors and practices in drug
management. These reports also served as a basis to map the drug
supply chain and document issues related to drug management.
Quantitative Analysis
The quantitative surveys consisted of the veterinary drug
profiling with retailers and the survey on knowledge, practices,
and awareness of veterinary practitioners about AMR and their
related practices.
For the drug profiling, data obtained was recorded in MS
excel to perform descriptive statistics. Generic drug names
and active ingredients were used to classify the drugs into
antibiotic, anthelminthic, arachnicide, vaccine, vitamin and iron
supplement, antiprotozoal, disinfectant, anti-inflammatory and
microbial supplement. Antibiotics were classified following OIE
guidelines (11) into aminoglycosides, penicillins, quinolones,
macrolides, polypeptides, sulphonamides, and tetracyclines.
For the knowledge, practice and awareness survey with
veterinary practitioners, data was exported from the ODK
server to STATA 15 (StataCorp) for further analysis. Descriptive
statistics (frequencies and proportions) were carried out and
whenever relevant, between districts comparisons were done
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FIGURE 1 | Veterinary drug and vaccine supply chains in Uganda. The flux distribution was determined based on perception of stakeholders (Full line = high flux
distribution channel; Dotted line = low flux distribution channel); *Public veterinary services procure mainly vaccines for endemic diseases and acaricides; Continuous
loop indicated the back-and-forth sales among same stakeholders. The determination of the flux was based on the knowledge and perception of stakeholders.
using chi-square test. To analyse factors associated with
appropriate knowledge of AMR by veterinary practitioners,
a univariable analyse and a backwards stepwise selection
Generalized Linear Models (GLM) was used. Each knowledge
related question (Appendix 1) was independently analyzed by
assigning a score to responses, either one (correct or appropriate
response) or zero (incorrect or non-appropriate response). The
scoring was done by the first author who is a veterinarian. To
analyse how veterinary practitioners performed in the knowledge
of AMR, the sum of each participant’s answers was calculated.
Those whose answered 70% or more correct were deemed
to have good knowledge of antibiotics and AMR. Covariates
with a p < 0.05 were included in the final multivariable
analysis using GLM with a Poisson log linear link function,
which was run in Stata package (StataCorp) version 14 to
test the effect of different factors on the outcomes of interest
(knowledge of AMR). A two-sided p < 0.05 was considered
statistically significant.
RESULTS
Qualitative Assessment and Description of
the Veterinary Drug Supply Chain in
Uganda
Map of the Veterinary Drug Supply Chain
The supply of veterinary drugs in Uganda is made up of several
actors who play distinct but complementary roles and who are
mainly from the private sector. Drug manufacturers are the first
level of actors (Figure 1). They are mostly based abroad and
include international reputed pharmaceutical companies which
have established a market in Africa. The primary wholesalers
(or drug importers/distributors) are in the country and they
hold large-scale business dealing directly with manufacturers.
They supply drugs to secondary wholesalers and retailers,
and to some extent to AHSPs and to the government. The
secondary wholesalers hold medium scale businesses and mainly
redistribute drugs to retailers (also called drug stockists) and to
AHSPs such as veterinarians and para-veterinarians, who supply
to farmers some of whom practice self-medication. Primary
and secondary wholesalers have their main branches located in
the capital city in Kampala. Drug retailers are located in the
regions (or districts), and around municipalities from where they
have access to infrastructures such as electricity. They mainly
supply drugs to AHSPs and to livestock farmers. Drug retailers
consider farmers as their first-choice customers because they
pay higher prices as compared to AHSPs, who tend to bargain
for lower prices as they have better market information of the
products from wholesalers. Secondary wholesalers and retailers
stock drugs based on demand forecasts, price, and profit margin.
The transactions costs and their poor bargaining power may
result in weak incentives for them to stock a wide variety of
products or brands, leading to frequent shortage of products in
the market. The government procures veterinary products for
public use, especially livestock vaccines and acaricides, mainly
from primary wholesalers.
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The secondary wholesalers and retailers could buy drugs
among themselves to accommodate market demand. This
situation happens when a drug is scarce in some areas and is on
excess in another area. The markets are constantly fluctuating,
and products change hands many times. The determination of
product prices at the supplier and the retailer nodes depends
on the transaction costs incurred, mainly transport and storage.
The distributors normally add a 15% charge for transport from
the manufacturer to the primary wholesaler and a 30% mark-
up (for distributor profit). The drug retailer stationed in the
district adds a 30% for profit margin. At the farmer node,
the cost of the drug is included in the service package of
the AHSP.
The role of government in regard to regulation of veterinary
drugs is divested to the NDA within the Ministry of Health. The
NDA mandate includes supervision and control of importation,
exportation of pharmaceuticals, promotion, and control of
local drug production, as well as encouraging research and
development of herbal medicines. Wholesalers and retailers hold
a practice license provided by the NDA, which conducts routine
monthly visits to drug dealers’ premises to ensure compliance
with regulations. The role of the Ministry of Agriculture, Animal
Industry and Fisheries (MAAIF) is to provide extension and
sensitization and capacity building of actors in the supply chain.
Challenges Reported by Drug Supply Chains Actors
The supply chain actors reported several constraints they face
in the drug business. For example, repackaging of product in
smaller units happens at different nodes of the supply chain. This
practice can lead to product deterioration following exposure to
abnormal temperature and sun light. There is weak enforcement
of regulations such as quality control assurance which may
accelerate proliferation of falsified or substandard products into
the market. Actors reported that wholesalers do not have the
same standard operating procedures for marketing drugs, as they
all manage the product using own standards, which complicates
quality control, thus absence of accountability if something goes
wrong in the field including treatment failure or drug expiry.
There is continuous questioning of farmers about the quality
of drugs they receive since there are reported cases of poor
effectiveness of some drugs after use. Regarding this, there is a
blame game going on between retailers and farmers who accuse
each other of being responsible for poor-quality drugs following
poor storage and handling by retailers or inappropriate use
by farmers.
Constraints reported by drug retailers include high
transactions costs leading to high cost of the drugs, and
consequently low profit margins particularly for small businesses
that do not have sufficient financial capital. Uncontrolled
transactions result in unethical competition, sidelining the small
business owners, who then escape quality control.
Furthermore, farmers’ fixed mindset does not enable smooth
transition to accommodate new drugs in the market and is
a barrier to drug uptake. For instance, farmers usually stick
to known brands and are not flexible to change even though
the active ingredient are the same. This situation prevents
new drugs from penetrating the market, resulting in a limited
range of options to farmers. Limited financial and human
resources by authorities in charge of regulation of the drug
supply chain were reported as a major challenge. According
to stakeholders, inappropriate implementation of policies has
led to lack of incentive of actors to comply to regulation. For
example, lack of supportive measures such as compensation after
drug confiscation by NDA makes some drug users not to report
cases of drug expiry. Therefore, there has been an influx of
substandard quality drugs in the market. The poor-quality drug
or “fake drug” phenomenon was commonly pointed out by all
actors as being a major issue. This is when a drug comes from
a suspicious origin (e.g., unknown dealer to the community),
or when farmers are deceived by health workers of treating
non-curable diseases such as African swine fever. According to
stakeholders, self-medication has gained ground, following poor
access to quality drugs by farmers. It is therefore difficult to
situate the responsibility of poor quality or “fake drug” when
there is no traceability of products.
The actors recognize that there are gaps in the existing policy
governing delivery of veterinary drugs, hence such a policy ought
to be revised. A major gap identified is the poor collaboration
between government bodies who play important roles in the
delivery of drugs, and the laborious protocols and procedures for
registering new drugs, leading to stakeholders taking “shortcuts”
to release the product in the market. The actors also stressed the
need to set-up regulatory authorities/bodies to track unqualified
personnel. Major challenges reported by regulators include lack
of personnel at district level; and lack of laboratory capacity for
quality control especially for identifying fake drugs. They also
mentioned that products licensed by NDA are of good quality
and are efficient however drug stockists reduce the efficiency of
the drugs through their practice. Poor practices of drug stockists
include reconstitution of vaccines for retail sale or dividing the
vaccine capsules; sale of expired drugs to farmers by changing
labels to extend the shelf life of drugs or altering the expiry dates
and also repackaging drugs. Therefore, drug shops are limited
on the amount of stock at a given time as well as bulk packs.
They further stated that the problem was not the drugs but the
government policy of liberalization where everyone can run a
drug shop for the money and not as a form of service.
Veterinary Drug Profiling and Drug Sale
Practices
Sociodemographic Characteristics of Drug Retailers
Most drug retailers interviewed in Mukono and Lira were male,
holding either a diploma or a lower academic qualification
(Table 2).
Category of Antibiotics Stocked by Retailers
In total 1,172 drug brand names were recorded from the 23
drugs retail shops in districts of Lira, (29%) and Mukono (71%).
Antibiotics (33%) and anthelminthics (26%) were the most
stocked drugs by retailers in Lira district, while antibiotics (28%)
and vitamins/minerals (25%) represented the most stocked drugs
by retailers in Mukono district (Figure 2).
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TABLE 2 | Demographic characteristics study participants (drug retailers) by district.
Variable Category Lira (n = 10) Mukono (n = 13)
Gender of respondent Male 8 (80%) 7 (54%)
Female 2 (20%) 6 (46%)
Academic qualification Bachelor of Science veterinary medicine 1 (10%) 1 (8%)
Diploma in animal production* 4 (40%) 9 (69%)
Certificate in animal production* 3 (30%) 2 (15%)
Primary education 1 (10%) 0 (0%)
Unknown 1 (10%) 1 (8%)
*Diploma and certificate programs help prepare students for higher education and advance their careers. They are usually short in length since they are intended to cover specific areas.
FIGURE 2 | Drugs and supplies/biologicals stocked in shops in Lira and Mukono districts. Other Category Includes Growth Promoters, Feed Additives,
Detergents, Sedatives.
The most common classes of antibiotics recorded in both
districts were tetracyclines (53%) and sulphonamides (18%),
followed by macrolides (9%) and quinolones (7%). Polypeptides
and aminoglycosides were the least frequently recorded group
of antibiotics and were only found in Mukono. Within the
class of tetracyclines, oxytetracycline was the most frequently
encountered antibiotic compound; while sulfadimidine was the
most frequently encountered antibiotic compound within the
class of sulphonamides. All antibiotic compounds, except tylosin,
were reported to have been in the market for at least 15
years, with oxytetracycline and procaine penicillin being the
oldest with 30 years. Tylosin was reported to be the newest
antibiotic substance on the market, available since about 8
years (Table 3).
According to the drug producer recommendations,
the main routes of administration of antibiotics to
livestock as recorded from the package were oral (51%),
followed by intramuscular injection (15%) and topical
application (13%). Other administration routes include
sub-cutaneous, intra-uterine, intramammary, eye drop
and intravenous.
Practices of Drug Retailers and Factors Influencing
Drug Choice by Buyers
From the retailer’s point of view, there is no restriction to whom
they sell drugs to, and most of the time, buyers (mostly farmers
and veterinary practitioners) ask for a drug they want by its
trade name. This is influenced by their experience with these
drugs or the duration of use of the drugs (usually those that have
been on the market for long). Farmers mostly stick to the drugs
they know and have been using in the past; they are reluctant
to change to drugs that are new in the market. The cost of
the drug was also mentioned as a factor that influences choice
of the buyer, as some buyers weigh prices of different drugs
and opt for the cheapest option. Location (drug shop close to
client) was an important factor, and we observed that the urban
shops received the most clients. Perceived effectiveness of the
drug experienced by the buyer was another factor affecting drug
purchase. It was reported that farmers communicate drug success
or failure and recommend drugs that work to each other. When
a buyer comes without prior knowledge, recommendations are
made by the retailer based on the buyer’s description of the
clinical signs of the disease. From a AHSP perspective, the choice
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TABLE 3 | Classes of antibiotics stocked in retail shops in Lira and Mukono districts.
Antibiotic class Lira, n = 114 Mukono, n = 234 Total, n = 348 Antibiotic compound per antibiotic class
Tetracycline 67 (59%) 118 (50%) 185 (53%) Oxytetracycline, 93%
Oxytetracycline cocktail**, 6%
Doxycycline, 1%
Sulphonamide 18 (16%) 44 (19%) 62 (18%) Sulfadimidine, 32%
Trimethoprim + Sulfamethazine, 29%
Trimethoprim + Sulfadiazine, 27%
Sulfamonomethoxine, 7%
Sulphadimidine cocktail*, 5%
Macrolide 7 (6%) 23 (10%) 30 (9%) Tylosin, 80%
Erythromycin 20%
Quinolone 3 (3%) 20 (9%) 23 (7%) Enrofloxacin, 87%
Flumequin, 13%
Penicillin + Aminoglycoside 10 (9%) 9 (4%) 19 (5%) Procaine penicilin + Dihydrostreptomycin, 83%
Procaine penicilin + Neomycin +
Streptomycin, 17%
Penicillin 6 (5%) 9 (4%) 15 (4%) Cloxacillin benzathine, 92%
Amoxicillin, 8%
Aminoglycoside 3 (3%) 9 (4%) 12 (3%) Gentamicin, 75%
Neomycin, 25%
Polypeptide 0 (0%) 2 (1%) 2 (1%) Colistin, 100%
*Sulphadimidine + diaveridine, excipient, vit K.
**Oxytetracyclin + hydrochloride, neomycin sulfate, Vits A, D3, E B1,2, 6,12 K3, C, and Oxytetracyclin + nicotinamide, folic acid, methionine, lysine or Vits A, D3, E, K3, B2, B 12.
of a drug takes into account the administration mode of the
drug (easier to administer, not requiring lot of restraining as
in the case of injectables), the preference of the farmer (single
dose not requiring follow-up), the cost of the drug (affordable for
the farmer). Given that most of the times there is no laboratory
diagnostics carried out prior to treatment, ASHPs prefer broad
spectrum anthelminthics such as ivermectin (targets internal
and external parasites), or antibiotics such as oxytetracycline.
Aliquoting drugs into small doses is common for buyers who
cannot afford to buy the whole pack. This is carried out
using syringes, empty drug containers, including empty vials
dedicated for human drugs which are used to aliquot mostly
injectable drugs.
Drug retailers noted that there is continuous advice to buyers
about usage of drugs (dosage or usage frequency and duration of
usage), especially for arachnicides and poultry drugs that require
mixing or dilution before use. Most drug shops had a certificate
of operation on display with the respective qualifications
mentioned. However, the person whose qualification is displayed
was most of the times not the person interviewed, nor the
one doing the sales. We also noticed that drug shops are
sometimes run as family business and a family member with no
qualifications in animal health or animal production is involved
in the sale of drugs. This helps cut expenses and probably
tackles unemployment given the high unemployment rates in
the area. Another scenario is that a person without specific
veterinary sciences training is sometimes hired. It is also common
for agricultural shops to get involved in the sale of veterinary
drugs, although they are not licensed by the NDA. They sell
“fast moving” drugs like oxytetracyclines, acaricides and wound
sprays. It is however unlikely that someone would see these drugs
as they are kept away from display and only brought out when a
trustworthy client asks for them.
Survey With Veterinary Practitioners on
Knowledge, Practices, and Awareness
About AMR and Perception of Related
Policies
Demographics and Services Delivered by Veterinary
Practitioners Use
Majority of veterinary practitioners who took part in the survey
were male mainly offering disease treatment services only. Most
of them hold a diploma and have been practicing for at least 5
years (Table 4).
Antibiotics were mentioned to be the most profitable drug
category for veterinary practitioners (Lira, 81% and Mukono,
59%). In both districts, practitioners dealt mostly with cattle and
pigs. Practitioners who dealt with poultry were only registered in
Mukono district. Most veterinary practitioners provided drugs to
small scale farmers (Lira, 84%; Mukono, 73%) (Table 5).
Most veterinary practitioners reported administering drugs to
animals or selling drugs to farmers without prescription (Lira,
37%; Mukono, 40%). They mostly decided on drugs based on
symptoms as described by the farmer and verified by themselves
(Lira, 75%; Mukono, 78%), or based on their own judgement
following a farmer’s explanation without seeing the animal (Lira,
25%; Mukono, 21%). Dosage was generally determined following
instructions on the drug packaging, while weight of the animal
was estimated by the farmer or the practitioner. According to
practitioners, most farmers in Lira (87%) administered the drugs
to animals by themselves. Drugs were mostly sold as single tablets
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TABLE 4 | Demographic characteristics of veterinary practitioners.
Variable Category Lira (n = 32) Mukono (n = 68)
q8-Gender of respondent Male 29 (91%) 59 (87%)
Female 3 (9%) 9 (13%)
q10-Nature of the business Practicing treatment only 29 (91%) 49 (72%)
Practicing treatment and drug retail shop 3 (10%) 19 (28%)
q11-Years in business 0–1 year 1 (3%) 5 (7%)
2–4 years 9 (28%) 12 (18)
5–10 years 14 (44%) 24 (35%)
More than 10 years 8 (25%) 27 (40%)
q12-Academic qualification Bachelor of Veterinary Medicine 1 (3%) 4 (8%)
Bachelor of Science 0 (0%) 6 (6%)
Diploma 21 (66%) 35 (51%)
Certificate 5 (16%) 20 (29%)
High school 1 (3%) 2 (3%)
Primary school 4 (12%) 1 (2%)
TABLE 5 | Characteristics of business delivered to farmers by veterinary practitioners.
Variable Category Lira (n = 32) Mukono (n = 68)
q17-Drug category important for the business Antibiotics 26 (81%) 40 (59%)
Antihelmintics 5 (16%) 18 (26%)
Arachnicides 0 (0%) 3 (4%)
Vaccines 1 (3%) 7 (10%)
Vitamins 0 (0%) 0 (0%)
q13-Livestock dealt with most Cattle 27 (84%) 34 (50%)
Pigs 5 (16%) 20 (29%)
Poultry 0 (0%) 13 (19%)
Sheep/goats 0 (0%) 1 (1%)
q16-Customer to veterinary practitioners Small scale farmer 26 (84%) 49 (73%)
Large scale (commercial) farmers 5 (16%) 18 (27%)
by 25% of practitioners in Mukono, while 65% of practitioners
said they provide enough drugs for the whole course of treatment
with follow-up visits. There were complaints from several clients
(farmers) about treatment failure (Lira, 44%; Mukono, 74%).
Arachnicides/acaricides were reported to be the drug that failed
most, followed by antibiotics and antihelminthics (Table 6).
Awareness and Knowledge of Veterinary
Practitioners About AMR
Most veterinary practitioners had heard about AMR (Lira,
75%; Mukono, 79%) mainly through one-to-one communication
among practitioners (50% and 35%, respectively, in Lira and
Mukono). Other important awareness channels include during
training sessions organized by government, by development
organizations, broadcasting (radio and television), newspapers,
and internet. The role of antibiotics was moderately understood,
with majority of practitioners correctly indicating that antibiotics
are effective in managing bacterial infections (Lira, 72%;
Mukono, 75%). Knowledge about antibiotic residues in animal
source foods such as meat and eggs and knowledge about
withdrawal periods and processes of acquiring antibiotics
residues through food products was very high. However, the
ways humans can acquire resistance to antibiotics was not well-
understood (Table 7).
Factors That Influence Knowledge of Veterinary
Practitioners About Antibiotics and AMR
Awareness of veterinary practitioners about AMR, district of
origin (Lira) and category of clients (small scale farms) had a
positive effect on knowledge of veterinary practitioner about
AMR (Table 8).
Perception of Veterinary Practitioners About Critical
Actions to Mitigate AMR
Many veterinary practitioners were not conversant about
veterinary drug policies of the country, with Mukono having
a higher number (72%) compared to Lira (37%). However, the
most urgent capacity needs according to practitioners in Lira
were a better understanding of the policies about the use of
veterinary drugs in the country and a better knowledge on how to
use AMs in livestock.While inMukono, the most urgent capacity
needs were the understanding of the mechanism of AMR and a
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TABLE 6 | Practices of veterinary practitioners in drug use.
Variable Category Lira (n = 32) Mukono (n = 68)
q21-Sale of drugs to farmers On prescription only (from another veterinary practitioner) 20 (63%) 41 (60%)
Both with and without prescription 12 (37%) 27 (40%)
Without prescription 0 (0) 0 (0%)
q24-Basis for deciding to administer or sell
antibiotic to farmers
Symptoms as explained by the farmer and verified by veterinary practitioner 24 (75%) 53 (78)
Laboratory test results provided by farmer or done by veterinary practitioner 0 (0%) 1 (1%)
Own judgement following farmers’ explanation (without seeing the animal) 8 (25%) 14 (21%)
q25-Estimation of dosage As indicated on the drug packaging 13 (41%) 21 (31%)
Own judgement based on experience of success 4 (12%) 26 (38%)
Estimated weight of the animal by farmer or practitioner 15 (47%) 20 (29%)
Other 0 (0%) 1 (1%)
q27-Way of administering the drug to animals Single dose/one-time measurement depending on the farmers’ capacity 2 (6%) 17 (25%)
Whole package for whole course of treatment 2 (6%) 44 (65%)
As indicated on drug packaging 0 (0%) 1 (1%)
I don’t administer* 28 (87%) 6 (9%)
q28-Drug failure reported by customers (farmers) Yes 14 (44%) 50 (74%)
No 18 (56%) 18 (26%)
q30-mnagement of expired drugs Discard 29 (91%) 56 (84%)
Never experienced 2 (6%) 2 (4%)
Return to National Dru Authority 0 (0%) 1 (1%)
Return to the wholesaler 1 (3%) 7 (10%)
Sell to clients at cheaper price 0 (90%) 1 (1%)
*These categories of animal health practitioners sell the drug to farmers who administer by themselves.
better knowledge on how to use AMs in livestock. Perception of
veterinary practitioners about critical actions for the sustainable
control of AMR include raising awareness of farmers about the
impact of misuse of antibiotics; re-enforcement of disease control
measures in livestock and stronger and directed policies on AM
use (Table 9).
DISCUSSION
The veterinary drug business in Uganda is largely driven by
private sector and is characterized by a diversity of actors who
play distinct but complementary roles. The drug business is
operated by personnel with sometimes limited training in drug
management, which is in line with findings of Ilukor et al.
(3) and Byarugaba (4) who reported that the animal health
sector in Uganda has a high percentage of non-trained service
providers. In most veterinary drug sale points, drugs can be
accessed by anyone (veterinary practitioners or not), regardless
of what drug is needed. This situation reflects the poor regulation
of the veterinary drug market. Lack of traceability of drugs
was widely pointed out by stakeholders as a major challenge
leading to proliferation of “fake drugs” in the market. According
to Granados-Chinchilla and Rodríguez (12), the Sub-Saharan
African market is highly affected by counterfeit veterinary
drugs. Though these counterfeit and non-compliance of drugs
can induce adverse effects during their utilization, there is no
monitoring system of veterinary medicines (13).
We found that all antibiotics (except tylosin) stored in drug
shops have been on the market for at least 15 years, suggesting
constant and wide use of these drugs in livestock. This situation
also points to the limited diversity in the antibiotic classes
marketed, with oxytetracycline and sulfadimidine being the
common antibiotics accessed by farmers for many years. A study
in Ghana, reported the same antibiotics to be commonly used in
livestock in many smallholder livestock (14). Tetracyclines are
a family of compounds frequently employed due to their broad
spectrum of activity as well as their low cost, compared with other
antibiotics. Currently, there are over 20 tetracyclines available;
however, tetracycline, chlortetracycline, oxytetracycline, and
doxycycline are the most common ones in veterinary medicine
(15). In addition to therapeutic purposes, in many other
countries, tetracyclines are often incorporated into livestock feed
at subtherapeutic doses as growth promoters for swine and
poultry and in aquaculture (12).
The lack of diversity in the use of drugs reflects the low
level of sophistication of the drug market in Uganda, which
is likely linked to the limited disease diagnostic capacities
that prevail, hence restricting the choice of drugs, therefore
leading to the constant use of broad-spectrum antibiotics more
frequently. However, this lack of diversity in the use of drugs
could also be a good thing as it reduces the risk of multidrug
resistance to several classes of antimicrobials; considering the
fact that that excessive use of antibiotics in humans leads to
emergence of resistant organisms (16). The criteria for choosing
a drug by veterinary practitioners which were mainly based
on their experience with the drug was rather subjective; hence
the change of giving a wrong treatment to animal is high.
This is exacerbated by the fact that in most African countries
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TABLE 7 | Knowledge of veterinary practitioners about roles of antibiotics and antibiotic resistance.
Variable Category Lira, n = 32 Mukono, n =
68
P-value
Awareness about antibiotic resistance
q31-Heard about antibiotic resistance phenomenon Yes 24 (75%) 54 (79%) 0.619
No 8 (25%) 14 (21%)
q32-antibiotic resistance awareness channel Learned about AMR from my background training 8 (34%) 22 (41%) 0.615
Heard from radio 2 (8%) 2 (4%)
Learnt from a colleague 12 (50%) 19 (35%)
Learnt from a short training/workshop 2 (8%) 9 (16%)
Red from newspaper 0 (0%) 1 (2%)
Other 0 (0%) 1 (2%)
Drivers of antibiotic resistance
q37-Antibiotic resistance is caused by using antibiotics
when not indicated
Agree 19 (59%) 49 (72%) 0.205
Disagree 13 (41%) 19 (28%)
Roles of antibiotics
q38-Antibiotics are effective in managing bacterial
infections
Agree 23 (72%) 51 (75%) 0.740
Disagree 9 (28%) 17 (25%)
q39-Antibiotics are effective in managing viral infections Agree 4 (12%) 30 (44%) 0.002**
Disagree 28 (88%) 38 (56%)
q40-Antibiotics are effective in managing protozoal
infections
Agree 27 (84%) 49 (72%) 0.179
Disagree 5 (16%) 19 (28%)
q41-Antibiotics are effective in managing parasitic
infections
Agree 6 (19%) 5 (7%) 0.089
Disagree 26 (81%) 63 (93%)
q45-Antibiotics are effective in managing pain and
inflammation
Agree 27 (84%) 53 (78%) 0.453
Disagree 5 (16%) 15 (22%)
q43-Antibiotics are effective in boosting animal growth Agree 25 (78%) 19 (28%) 0.000**
Disagree 7 (22%) 49 (72%)
Antibiotic residues
q44-Residues of antibiotics can be found in meat Agree 31 (97%) 61 (88%) 0.218
Disagree 1 (3%) 7 (10%)
q45-Residues of antibiotics can be found in milk Agree 31 (97%) 59 (87%) 0.116
Disagree 1 (3%) 9 (13%)
q46-Residues of antibiotics can be found in eggs Agree 26 (81%) 51 (75%) 0.488
Disagree 6 (19%) 17 (25%)
How is antibiotic resistance acquired
q47-People can acquire resistance through consuming
animal products that contain residues of antibiotics
True 31 (97%) 59 (87%) 0.231
False 1 (3%) 4 (13%)
q48-People can acquire resistance through direct bodily
contact with sick animals
True 12 (37%) 32 (47%) 0.279
False 20 (63%) 36 (53%)
q49-People can acquire resistance through contact with
animal feces
True 20 (62%) 43 (63%) 0.472
False 12 (36%) 25 (34%)
q50-People can acquire resistance through body fluids
of sick animals
True 29 (91%) 57 (84%) 0.585
False 3 (9%) 11 (16%)
Withdrawal periods
q53-Observance of withdrawal period makes the animal
product safer for human consumption
Agree 31 (97%) 63 (94%) 0.086
Disagree 1 (3%) 4 (6%)
**significant at P < 0.05.
such as Uganda, there inappropriate limited diagnostic facilities
including antimicrobial sensitivity testing (10). Previous studies
in Uganda by Dione et al. (17) and Ilukor and Birner (18)
reported that incorrect diagnosis, under-dosing and overdosing
and wrong drug administration routes, poor handling and
storage of drugs were common practice among farm households
and service providers in pig and cattle production systems,
respectively. In fact, service providers were found not to be
able to prescribe correct drugs for treatment of specific cattle
diseases (18). Although the link between stakeholder practices
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TABLE 8 | Factors associated with knowledge of veterinary practitioner about antibiotics and AMR.
Poisson regression Number of obs. = 65
Wald chi2(9) = 48.58 Prob > chi2 = 0.0000
Pseudo R2 = 0.0374 Log pseudolikelihood = −122.00191
Variable Coef. Robust Std. Err. z P>z [95% confidence interval]
Determination of dosage by farmer
Own judgment
As indicated on the drug pack 0.092218 0.0528942 1.740 0.081 −0.01145 0.195889
Heard about AMR
No*
Yes 0.2543311 0.0922078 2.760 0.006** 0.073607 0.435055
Category of clients
Small scale farms*
Large scale farms −0.1404909 0.0595735 −2.360 0.018** −0.25725 −0.02373
Level of education of veterinary practitioners
Primary*
Diploma 0.0640564 0.06002 1.070 0.286 −0.05358 0.181693
BVM 0.119419 0.0726594 1.640 0.100 −0.02299 0.261829
Most important drugs in the business
Antihelminthics*
Antibiotics −0.0215451 0.0625481 −0.340 0.731 −0.14414 0.101047
Arachnicides/vaccines 0.1090097 0.0792294 1.380 0.169 −0.04628 0.264297
District of operation
Mukono*
Lira 0.2139437 0.0693367 3.090 0.002** 0.078046 0.349841
Most frequent way of administering the drug to animals
Whole course of treatment as recommended*
Single dose/one-time application −0.0347081 0.0525027 −0.660 0.509 −0.13761 0.068195
_cons 1.441464 0.0934914 15.420 0.000 1.258224 1.624704
*reference; **significant at P < 0.05.
TABLE 9 | Actions needed to control AMR according to veterinary practitioners.
Variable Category Lira Mukono
q55-I am conversant about the veterinary drug policy of
Uganda
Agree 20 (63%) 19 (28%)
Disagree 12 (37%) 49 (72%)
Total 32 (100%) 68 (100%)
q59-Urgently needed to mitigate AMR Knowledge on how to use AMs 8 (25%) 15 (22%)
Understand mechanisms of AMR 6 (19%) 29 (43%)
Knowledge on when to prescribe AMs 3 (9%) 5 (7%)
Understand links between the health of humans, animals and the environment 5 (16%) 7 (10%)
Understand the policies about the use of veterinary drugs in the country 10 (31%) 12 (18%)
Total 32 (100%) 68 (100%)
q60-Critical actions for the sustainable control of AMR Stronger and directed policies on AM use 10 (31%) 35 (52%)
Raise awareness of farmers about the impact of AM misuse 13 (41%) 24 (35%)
Strict monitoring of drug import into the country 2 (6%) 4 (6%)
Re-enforce disease control in livestock 5 (16%) 1 (2%)
Enhance disease diagnostic in livestock 0 (0%) 1 (2%)
Strengthen quality control of drugs stocked in the country 2 (6%) 3 (4%)
Total 36 (100%) 78 (100%)
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and AMR is still weak, according to Ayukekbong et al. (10),
the lack of appropriate quality control regulations as reported in
the distribution of veterinary of drugs including antimicrobials
could be a contributing factor to the misuse of antimicrobials;
consequently, any imprudent practice along drug supply chain
may fuel the emergence of resistance.
Pig/poultry and cattle farmers were the main customers
of the drug, in Mukono and Lira districts, respectively. This
can be explained by the difference in livestock production
systems between the two districts: Lira district has a more
rural production system with more cattle-farming, compared to
Mukono which is characteristic of a peri-urban farming with
increasing poultry and pig production. There was no market for
antibiotics in small ruminant production in the studied districts.
This could be explained by the fact that small ruminants are less
market oriented; hence they are kept in low input systems with
low investment of farmers on drugs and other inputs such as feed.
High awareness of veterinary practitioners about antibiotic
residues in animal products and the importance of drug
withdrawal time was reported in the study. However, it was not
clear if practitioners advised farmers accordingly. The fact that
there is lack of effective monitoring system for drug residues
along the food supply chain in Uganda, makes it difficult to
assess eventual risks to consumers. However, it is important to
note that the profile of antibiotics reported in our study such as
tetracyclines, sulfamidines and sulfamethoxazole-trimethoprim
matches those of AMR reported in several studies in Uganda
(19–21). Low resistance was reported in Uganda for the less
commonly accessible antibiotics reported in our study such as
ciprofloxacin and gentamicin (19, 21). Furthermore, another
study (19) showed that AMR correlated negatively with the
local price of the antibiotic, with the most expensive antibiotics
(nalidixic acid and ciprofloxacin) showing near-zero resistance.
These findings are in line with ours where accessible antibiotics
are those that are said to be more affordable.
Awareness about AMR is an important factor identified
for understanding the roles of antibiotics among veterinary
practitioners, as is education. Both drug retailers and veterinary
practitioners operate in an environment, which seems to be
driven by financial profit, rather than quality of service to the
end-users. This is aggravated by the low purchase capacity of
farmers who aim to optimize investment for financial return
from the farm. Therefore, quality of products seems not to be
a focus, especially when regulators do not have a full hand
on this. According to Byarugaba (4), the weaknesses in the
implementation of policies are a challenge to sustainable drug
resistance control and prevention of AMR as these laws exist only
on paper or are poorly communicated to the stakeholders and
also their implementationmay be difficult due to poor funding. A
possible underlying cause of this could be the lack or inadequate
consultation when developing the policies. While the need for an
improved policy environment of veterinary drug management is
urgent, resulting policies and regulations should not undermine
the business capacities of input suppliers, but the focus should be
on increasing their knowledge on AMR and clearly defining their
roles in supporting prevention of AMR.
CONCLUSION
Our study investigated the veterinary drug supply chain, the
knowledge, practices, awareness and practices of veterinary
practitioners on antimicrobial usage, and the related policy
landscape. The common classes of antibiotics recorded in
both districts were tetracyclines. Stakeholders of the drug
supply chain pointed out lack of traceability of products as
a major contributor to poor quality of drugs found in the
market. Potential drivers of misuse of antibiotics, include
low level of education of actors such as drug retailers,
veterinary practitioners, poor handling of drugs at purchase
and administration practices, low enforcement of policy and
regulations and lack of awareness of stakeholders about policies
that regulate use of drugs. Thus, future interventions to
reduce misuse of drugs in small-scale livestock production
systems should target improvement of the business of veterinary
drug input suppliers, and deliberately involve a strong policy
advocacy component.
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